FDA Warns Australian Firm for GMP Violations

Drug Industry Daily
A A
The FDA hit Australian drugmaker Delta Laboratories with a warning letter for significant violations, including unreliable manufacturing processes, flawed stability testing and a lack of stability data.

To View This Article:

Login

Subscribe To Drug Industry Daily